FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q37307583> ?p ?o ?g. }

• Q37307583 description "article científic" @default.
• Q37307583 description "article scientifique" @default.
• Q37307583 description "articolo scientifico" @default.
• Q37307583 description "artigo científico" @default.
• Q37307583 description "artículu científicu espublizáu en 2008" @default.
• Q37307583 description "bilimsel makale" @default.
• Q37307583 description "scientific article published on March 2008" @default.
• Q37307583 description "vedecký článok" @default.
• Q37307583 description "vetenskaplig artikel" @default.
• Q37307583 description "videnskabelig artikel" @default.
• Q37307583 description "vědecký článek" @default.
• Q37307583 description "wetenschappelijk artikel" @default.
• Q37307583 description "wissenschaftlicher Artikel" @default.
• Q37307583 description "наукова стаття, опублікована в березні 2008" @default.
• Q37307583 description "научни чланак" @default.
• Q37307583 description "مقالة علمية نشرت في مارس 2008" @default.
• Q37307583 name "Alemtuzumab in the treatment of fludarabine refractory B-cell chronic lymphocytic leukemia (CLL)." @default.
• Q37307583 name "Alemtuzumab in the treatment of fludarabine refractory B-cell chronic lymphocytic leukemia (CLL)." @default.
• Q37307583 name "Alemtuzumab in the treatment of fludarabine refractory B-cell chronic lymphocytic leukemia" @default.
• Q37307583 type Item @default.
• Q37307583 label "Alemtuzumab in the treatment of fludarabine refractory B-cell chronic lymphocytic leukemia (CLL)." @default.
• Q37307583 label "Alemtuzumab in the treatment of fludarabine refractory B-cell chronic lymphocytic leukemia (CLL)." @default.
• Q37307583 label "Alemtuzumab in the treatment of fludarabine refractory B-cell chronic lymphocytic leukemia" @default.
• Q37307583 prefLabel "Alemtuzumab in the treatment of fludarabine refractory B-cell chronic lymphocytic leukemia (CLL)." @default.
• Q37307583 prefLabel "Alemtuzumab in the treatment of fludarabine refractory B-cell chronic lymphocytic leukemia (CLL)." @default.
• Q37307583 prefLabel "Alemtuzumab in the treatment of fludarabine refractory B-cell chronic lymphocytic leukemia" @default.
• Q37307583 P1433 Q37307583-6F8952D4-726B-4826-860E-23F99EE7768D @default.
• Q37307583 P1476 Q37307583-8DF465CB-EFD5-4CDF-B416-B33E60BED116 @default.
• Q37307583 P2093 Q37307583-63FBC694-47A4-401A-8CD1-FED4A3256003 @default.
• Q37307583 P2093 Q37307583-761ADE96-0BE5-4EA6-970C-4A92534521A8 @default.
• Q37307583 P2093 Q37307583-88B87C0C-827D-4A4B-8BFB-FA975C898CD0 @default.
• Q37307583 P2093 Q37307583-ADAC83AF-24A5-4DF1-98DB-30CA07B90BCD @default.
• Q37307583 P2093 Q37307583-E4617D46-A12F-4DC4-A82C-BE5410E65A5D @default.
• Q37307583 P2860 Q37307583-01ACB557-328C-4527-BBE1-4EC575266C1C @default.
• Q37307583 P2860 Q37307583-04A46278-F22B-41DF-81DF-D33A442BAF87 @default.
• Q37307583 P2860 Q37307583-0C3D2B8E-9280-4520-9F9D-D3671CEFC180 @default.
• Q37307583 P2860 Q37307583-1B86D279-19F7-4376-B78A-8E45F73B66EE @default.
• Q37307583 P2860 Q37307583-24111039-D312-41C5-90C9-79A279ADFC7A @default.
• Q37307583 P2860 Q37307583-278EF84C-6A80-49F5-8001-37E3271026DB @default.
• Q37307583 P2860 Q37307583-2E146C58-CB8E-4DB7-BC1A-AC3307DCF4FA @default.
• Q37307583 P2860 Q37307583-2E49B274-ED69-4E9D-A82E-367055DBD345 @default.
• Q37307583 P2860 Q37307583-373D5767-7481-4B88-9D4F-DA2518D3C87B @default.
• Q37307583 P2860 Q37307583-40A253FF-E267-4D77-8CF5-231E0FC65334 @default.
• Q37307583 P2860 Q37307583-4A737CC2-6EC2-42D4-91A9-A39210D5A619 @default.
• Q37307583 P2860 Q37307583-4BE14953-5BAB-4654-ACF8-E5677727E74D @default.
• Q37307583 P2860 Q37307583-5F79E524-5B5B-4EB6-AFC7-44315A25AA4F @default.
• Q37307583 P2860 Q37307583-623CC153-D738-4D2C-9AB7-18CA873A19B9 @default.
• Q37307583 P2860 Q37307583-650F5D55-7308-4CF7-86D0-4BC1B103EDAA @default.
• Q37307583 P2860 Q37307583-73F5A0FA-9625-492C-B43F-D9A8FACB30C4 @default.
• Q37307583 P2860 Q37307583-76F10A57-C075-4CCA-876C-C5ADAE757867 @default.
• Q37307583 P2860 Q37307583-784E73DC-811A-4F94-9EEB-7559CE8F8012 @default.
• Q37307583 P2860 Q37307583-7CF798E8-4F73-4FF4-AC19-B252691885E0 @default.
• Q37307583 P2860 Q37307583-7D85C296-48DA-443E-AFE5-791675834739 @default.
• Q37307583 P2860 Q37307583-86C70B2B-8240-4A96-B2C7-5893C9450EE7 @default.
• Q37307583 P2860 Q37307583-8D3CAA95-AA36-478B-9305-BC95E4A52868 @default.
• Q37307583 P2860 Q37307583-8EF5AD6F-678A-4D53-AB8D-FA9826F368F9 @default.
• Q37307583 P2860 Q37307583-90C7AE20-84E4-4490-8427-3DE32BD318F3 @default.
• Q37307583 P2860 Q37307583-9253E52B-40EB-4035-9B7A-BC67A3529C3A @default.
• Q37307583 P2860 Q37307583-9A2750D8-DD6B-4F05-B6D8-EFFAE0715693 @default.
• Q37307583 P2860 Q37307583-9CD6991D-3A92-469E-AAA0-3B8AC9BCAB1B @default.
• Q37307583 P2860 Q37307583-9F87A6E0-2FDE-43C3-B4B5-990B4B52E3B4 @default.
• Q37307583 P2860 Q37307583-A55D414A-D04A-4820-9E72-70EB1D03C0B1 @default.
• Q37307583 P2860 Q37307583-B36775D1-4320-4C7B-AE2C-B0E46D2A2DAA @default.
• Q37307583 P2860 Q37307583-B52D6AD7-3143-43B1-9EF7-850AA87F625C @default.
• Q37307583 P2860 Q37307583-B8576866-DAEB-4A98-A5B2-B92B7F8ECE0C @default.
• Q37307583 P2860 Q37307583-BC8743A6-71DC-4BF3-A994-5C0FE3995F60 @default.
• Q37307583 P2860 Q37307583-C0929335-C314-4B8D-AAB8-5281E6C7303C @default.
• Q37307583 P2860 Q37307583-C2E9BC0B-AB2F-4F34-85D1-41E6D61910E3 @default.
• Q37307583 P2860 Q37307583-C47C929D-965F-43C5-BDA9-3BD835C87957 @default.
• Q37307583 P2860 Q37307583-C5B080CA-214C-4AB0-AD51-8CD09A43C33E @default.
• Q37307583 P2860 Q37307583-C5FBFE8C-D17E-4592-A8EE-200046D42163 @default.
• Q37307583 P2860 Q37307583-D076827B-189C-4BDA-901B-075B0F40A87D @default.
• Q37307583 P2860 Q37307583-D36DC272-5F42-4B24-BD48-22B2359DECA9 @default.
• Q37307583 P2860 Q37307583-D462BB2F-8967-488A-A081-57B1C06D9CA5 @default.
• Q37307583 P2860 Q37307583-D5308614-4580-42AA-98AE-B471273B896D @default.
• Q37307583 P2860 Q37307583-DE487D9B-3D4B-442D-876F-45D3E150E195 @default.
• Q37307583 P2860 Q37307583-E42EA829-7DCF-4352-94B2-681E1003BCFA @default.
• Q37307583 P2860 Q37307583-E901A276-A5B5-4DA5-9B92-B68614F74FB4 @default.
• Q37307583 P2860 Q37307583-ECE12B2E-C7BB-458A-B3FD-903A31917E85 @default.
• Q37307583 P2860 Q37307583-F1BE6160-E689-4881-B52C-9727896ACFC6 @default.
• Q37307583 P2860 Q37307583-F850B83B-D4D1-4ABE-8E20-8D4843BF1E6E @default.
• Q37307583 P2860 Q37307583-FB1F347E-E4DC-4A82-8EA5-AA2CD487D64F @default.
• Q37307583 P304 Q37307583-4C2A8B22-B42A-4654-A584-BA1C0C2CB888 @default.
• Q37307583 P31 Q37307583-0A85508F-2307-4F5F-91A2-E1B253101556 @default.
• Q37307583 P31 Q37307583-f265a50d-be67-46f1-ac65-95665cca1e7f @default.
• Q37307583 P356 Q37307583-C75CEB94-FF2E-4903-84A1-5C6C22204A26 @default.
• Q37307583 P433 Q37307583-63A40495-E5B8-4191-843F-B62E3F9D6FAA @default.
• Q37307583 P478 Q37307583-7C75A81A-6D31-40B2-B0FF-307F93006E92 @default.
• Q37307583 P577 Q37307583-C35ACA98-0849-4D3D-B4D6-6AA8C3C2BBFC @default.
• Q37307583 P698 Q37307583-14ECA3B2-0D36-4267-9FCC-ABA668EB4426 @default.
• Q37307583 P921 Q37307583-A15E4938-BE0C-45D1-A5B6-CD73C04475D2 @default.
• Q37307583 P921 Q37307583-A624420E-EABD-4340-9C3D-0844B291AC28 @default.
• Q37307583 P921 Q37307583-B396FC70-7BD7-43A4-BFE1-686749BF6F6A @default.
• Q37307583 P932 Q37307583-ECC33DEE-A9CA-4D57-AC83-5C8DC152D263 @default.
• Q37307583 P356 BTT.S1397 @default.
• Q37307583 P698 19707426 @default.
• Q37307583 P1433 Q4915042 @default.
• Q37307583 P1476 "Alemtuzumab in the treatment of fludarabine refractory B-cell chronic lymphocytic leukemia (CLL)." @default.
• Q37307583 P2093 "Alessandra Tedeschi" @default.
• Q37307583 P2093 "Enrica Morra" @default.

• next